Archives
Mental Health Implications In Patients With End-Stage Kidney Disease
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Mental Health Implications In Patients With End-Stage Kidney Disease
(followed by a live Q&A with our speakers)
Background:
Depression and anxiety are the most common mood disorders amongst ESKD patients, which can negatively affect patient outcomes.1 The impact in end-stage kidney disease is often underrecognized and bringing awareness to this issue is critical to improving the management and overall well-being of these patients.
Why watch this webinar?
This webinar will illuminate the burden of depression and anxiety in ESKD patients and the associated risk factors. Best practices and strategies for recognizing and discussing these concerns with patients will be shared.
What you will learn:
- Understand the mental health burden in ESKD and discuss current data on depression and anxiety in ESKD patients
- Elucidate the factors associated with depression and anxiety in ESKD patients
- Evaluate is the impact of depression and anxiety in ESKD patients
- Discuss the role of nephrologists and the healthcare team in managing depression and anxiety in ESKD patients
Reference:
- Al-Shammari N, Al-Modahka A, Al-Ansari E, et al. Prevalence of depression, anxiety, and their associations among end-stage renal disease patients on maintenance hemodialysis: a multi-center population-based study. Psychol Health Med. 2021 Oct;26(9):1134-1142. doi: 10.1080/13548506.2020.1852476. Epub 2020 Nov 29. PMID: 33251848.
Featuring
Fahad Aziz, MD
Division of Nephrology, Transplant Medicine*
Fahad Aziz, MD, FASN, is a faculty member in the Division of Nephrology within the Department of Medicine where he serves as the program director for the nephrology fellowship. As a clinical nephrologist, Dr Aziz cares for people living with a wide range of kidney diseases and disorders including renal transplant recipients. In addition to certification in the practice of internal medicine and nephrology, he holds Hypertension Specialist Certification from the American Society of Hypertension. Dr Aziz is a member of the American College of Physicians, the American Society of Nephrology (ASN), and the American Society of Transplantation (AST). During his residency training, he was awarded “Best Resident of the Year” on two occasions. He has presented clinical research at national medical conferences at ASN and AST professional society scientific meetings. As a medical educator, he has provided classroom instruction topics in nephrology to physician assistant students and nephrology fellows as well as continuing medical education presentations to clinicians.
Jaimini Patel, PharmD, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.
*Dr Fahad Aziz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jaimini Patel is an employee of OPDC.
